An open-label trial of milacemide in schizophrenia: an NMDA intervention strategy

Clin Neuropharmacol. 1990 Aug;13(4):348-54. doi: 10.1097/00002826-199008000-00010.
No abstract available

MeSH terms

  • Acetamides / adverse effects
  • Acetamides / therapeutic use*
  • Adult
  • Clinical Trials as Topic
  • Humans
  • Male
  • Pilot Projects
  • Psychiatric Status Rating Scales
  • Receptors, N-Methyl-D-Aspartate / drug effects
  • Receptors, N-Methyl-D-Aspartate / physiology*
  • Schizophrenia / drug therapy*
  • Schizophrenia / physiopathology

Substances

  • Acetamides
  • Receptors, N-Methyl-D-Aspartate
  • milacemide